{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:11:18Z","timestamp":1793257878141,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ijantimicag.2008.01.027","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T14:42:09Z","timestamp":1210084929000},"page":"561-566","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis"],"prefix":"10.1016","volume":"31","author":[{"given":"A.","family":"Ehnhage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rautiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.01.027_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(05)80320-6","article-title":"Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin","volume":"26","author":"Blumer","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib2","series-title":"Program and Abstracts of the 2006 American Thoracic Society (ATS) International Conference","article-title":"Single-dose azithromycin microspheres achieves improved lung pharmacokinetics versus azithromycin tablets.","author":"Danesi","year":"2006"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dki241","article-title":"Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models","volume":"56","author":"Girard","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.otohns.2005.04.020","article-title":"Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults","volume":"133","author":"Murray","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib5","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1378\/chest.128.4.2230","article-title":"Single-dose azithromycin microspheres vs. clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults","volume":"128","author":"Drehobl","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib6","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.49.10.4035-4041.2005","article-title":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults","volume":"49","author":"D\u2019Ignazio","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.idc.0000161504.41501.e7","article-title":"Novel, single-dose microsphere formulation of azithromycin versus levofloxacin for the treatment of acute exacerbation of chronic bronchitis","volume":"13","author":"Zervos","year":"2005","journal-title":"Infect Dis Clin Prac"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/420739","article-title":"Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis","volume":"38","author":"Ambrose","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.diagmicrobio.2006.10.019","article-title":"Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis","volume":"57","author":"Anon","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib11","unstructured":"Azithromycin [package insert]. New York, NY: Pfizer Inc.; 2006."},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/AAC.33.3.277","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection","volume":"33","author":"Gladue","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.01.027_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF01975841","article-title":"Azithromycin concentrations in sinus fluid and mucosa after oral administration","volume":"10","author":"Karma","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:29:02Z","timestamp":1557534542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0924857908000745"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.01.027","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}